Alnylam Pharmaceuticals Stock Market Value

ALNY Stock  USD 149.45  4.94  3.20%   
Alnylam Pharmaceuticals' market value is the price at which a share of Alnylam Pharmaceuticals trades on a public exchange. It measures the collective expectations of Alnylam Pharmaceuticals investors about its performance. Alnylam Pharmaceuticals is trading at 149.45 as of the 29th of March 2024; that is -3.2 percent down since the beginning of the trading day. The stock's open price was 154.39.
With this module, you can estimate the performance of a buy and hold strategy of Alnylam Pharmaceuticals and determine expected loss or profit from investing in Alnylam Pharmaceuticals over a given investment horizon. Check out Alnylam Pharmaceuticals Correlation, Alnylam Pharmaceuticals Volatility and Alnylam Pharmaceuticals Alpha and Beta module to complement your research on Alnylam Pharmaceuticals.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
Symbol

Alnylam Pharmaceuticals Price To Book Ratio

Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.52)
Revenue Per Share
14.637
Quarterly Revenue Growth
0.312
Return On Assets
(0.05)
Return On Equity
(15.01)
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Alnylam Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alnylam Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alnylam Pharmaceuticals.
0.00
04/09/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
03/29/2024
0.00
If you would invest  0.00  in Alnylam Pharmaceuticals on April 9, 2022 and sell it all today you would earn a total of 0.00 from holding Alnylam Pharmaceuticals or generate 0.0% return on investment in Alnylam Pharmaceuticals over 720 days. Alnylam Pharmaceuticals is related to or competes with Mustang Bio, and YS Biopharma. Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing nove... More

Alnylam Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alnylam Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alnylam Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.

Alnylam Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Alnylam Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alnylam Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Alnylam Pharmaceuticals historical prices to predict the future Alnylam Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alnylam Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
147.20149.45151.70
Details
Intrinsic
Valuation
LowRealHigh
109.84112.09164.40
Details
Naive
Forecast
LowNextHigh
150.55152.80155.06
Details
28 Analysts
Consensus
LowTargetHigh
208.74229.39254.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alnylam Pharmaceuticals. Your research has to be compared to or analyzed against Alnylam Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Alnylam Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals Backtested Returns

Alnylam Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18% return per unit of risk over the last 3 months. Alnylam Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alnylam Pharmaceuticals' Risk Adjusted Performance of (0.08), mean deviation of 1.53, and Standard Deviation of 2.23 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alnylam Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Alnylam Pharmaceuticals is expected to be smaller as well. Alnylam Pharmaceuticals has an expected return of -0.41%. Please make sure to confirm Alnylam Pharmaceuticals standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Alnylam Pharmaceuticals performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.41  

Modest reverse predictability

Alnylam Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between Alnylam Pharmaceuticals time series from 9th of April 2022 to 4th of April 2023 and 4th of April 2023 to 29th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alnylam Pharmaceuticals price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Alnylam Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient-0.41
Spearman Rank Test-0.44
Residual Average0.0
Price Variance315.52

Alnylam Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Alnylam Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alnylam Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Alnylam Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Alnylam Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Alnylam Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alnylam Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alnylam Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alnylam Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Alnylam Pharmaceuticals Lagged Returns

When evaluating Alnylam Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alnylam Pharmaceuticals stock have on its future price. Alnylam Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alnylam Pharmaceuticals autocorrelation shows the relationship between Alnylam Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Alnylam Pharmaceuticals.
   Regressed Prices   
       Timeline  

Alnylam Pharmaceuticals Investors Sentiment

The influence of Alnylam Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Alnylam. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Alnylam Pharmaceuticals' public news can be used to forecast risks associated with an investment in Alnylam. The trend in average sentiment can be used to explain how an investor holding Alnylam can time the market purely based on public headlines and social activities around Alnylam Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alnylam Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alnylam Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Alnylam Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals Implied Volatility

    
  37.39  
Alnylam Pharmaceuticals' implied volatility exposes the market's sentiment of Alnylam Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Alnylam Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Alnylam Pharmaceuticals stock will not fluctuate a lot when Alnylam Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Alnylam Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Alnylam Pharmaceuticals' short interest history, or implied volatility extrapolated from Alnylam Pharmaceuticals options trading.

Pair Trading with Alnylam Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alnylam Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Alnylam Stock

  0.83MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Alnylam Stock

  0.93EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.84MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.79MDWD Mediwound Downward RallyPairCorr
  0.51CLVRW Clever Leaves HoldingsPairCorr
  0.46MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Alnylam Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alnylam Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alnylam Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alnylam Pharmaceuticals to buy it.
The correlation of Alnylam Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alnylam Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alnylam Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alnylam Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alnylam Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alnylam Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alnylam Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alnylam Pharmaceuticals Stock:
Check out Alnylam Pharmaceuticals Correlation, Alnylam Pharmaceuticals Volatility and Alnylam Pharmaceuticals Alpha and Beta module to complement your research on Alnylam Pharmaceuticals.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Alnylam Stock analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Alnylam Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alnylam Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alnylam Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...